Skip to main content
Funded Studies

Cell-to-Cell Transport of Alpha-Synuclein

This grant builds upon the research from a prior grant: The Transfer of Alpha-Synuclein: Mechanistic and Therapeutic Studies

Study Rationale:                   
In Parkinson’s disease, the protein alpha-synuclein changes shape, and we think it transfers around the brain. We want to see if we can recreate this in non-human primates.

Hypothesis:
We are testing the hypothesis that we can get alpha-synuclein to transfer from site to site around the primate brain.

Study Design:
Eight models will be part of this study. Four will receive alpha-synuclein and four will receive placebo. After six months we will examine the model brain and analyze protein transference.

Impact on Diagnosis/Treatment of Parkinson’s Disease:             
This understanding will provide a model for which therapeutic strategies based upon the transfer of this modified protein can be tested.

Next Steps for Development:
We will use this model to test novel therapies aimed at preventing the transfer of alpha-synuclein around the brain.


Researchers

  • Jeffrey H. Kordower, PhD

    Tempe, AZ United States


Discover More Grants

Search by Related Keywords

Within the Same Program

Within the Same Funding Year

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.